Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E McNulty

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Cardiology|June 25, 2019
Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF TrialStephen J Greene, G Michael Felker, Anna Giczewska, et al.
ESC Heart Failure|August 19, 2018
Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trialAbhinav Sharma, Andrew P Ambrosy, Adam D DeVore, et al.
The New England Journal of Medicine|March 30, 2020
Vericiguat in Patients with Heart Failure and Reduced Ejection FractionPaul W Armstrong, Burkert Pieske, Kevin J Anstrom, et al.
ESC Heart Failure|June 1, 2021
Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failureAbhinav Sharma, Stephen Greene, Muthiah Vaduganathan, et al.
Circulation. Heart Failure|June 5, 2015
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF)Anuradha Lala, Steven E McNulty, Robert J Mentz, et al.
American Heart Journal|April 6, 2010
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT)Daniel B Mark, Kevin J Anstrom, Steven E McNulty, et al.
JAMA|August 3, 2016
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialKenneth B Margulies, Adrian F Hernandez, Margaret M Redfield, et al.
Circulation. Heart Failure|May 5, 2020
Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT TrialBrahim Redouane, Stephen J Greene, Marat Fudim, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
JAMA Cardiology|July 13, 2017
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical TrialJaved Butler, Kevin J Anstrom, G Michael Felker, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Cardiology|June 25, 2019
Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF TrialStephen J Greene, G Michael Felker, Anna Giczewska, et al.
ESC Heart Failure|August 19, 2018
Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trialAbhinav Sharma, Andrew P Ambrosy, Adam D DeVore, et al.
The New England Journal of Medicine|March 30, 2020
Vericiguat in Patients with Heart Failure and Reduced Ejection FractionPaul W Armstrong, Burkert Pieske, Kevin J Anstrom, et al.
ESC Heart Failure|June 1, 2021
Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failureAbhinav Sharma, Stephen Greene, Muthiah Vaduganathan, et al.
Circulation. Heart Failure|June 5, 2015
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF)Anuradha Lala, Steven E McNulty, Robert J Mentz, et al.
American Heart Journal|April 6, 2010
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT)Daniel B Mark, Kevin J Anstrom, Steven E McNulty, et al.
JAMA|August 3, 2016
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialKenneth B Margulies, Adrian F Hernandez, Margaret M Redfield, et al.
Circulation. Heart Failure|May 5, 2020
Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT TrialBrahim Redouane, Stephen J Greene, Marat Fudim, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
JAMA Cardiology|July 13, 2017
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical TrialJaved Butler, Kevin J Anstrom, G Michael Felker, et al.
Pageof 4